Unknown

Dataset Information

0

Novel HSP90-PI3K Dual Inhibitor Suppresses Melanoma Cell Proliferation by Interfering with HSP90-EGFR Interaction and Downstream Signaling Pathways.


ABSTRACT: Melanoma is the deadliest form of skin cancer, and its incidence has continuously increased over the past 20 years. Therefore, the discovery of a novel targeted therapeutic strategy for melanoma is urgently needed. In our study, MTT-based cell proliferation assay, cell cycle, and apoptosis assays through flow cytometry, protein immunoblotting, protein immunoprecipitation, designing of melanoma xenograft models, and immunohistochemical/immunofluorescent assays were carried out to determine the detailed molecular mechanisms of a novel HSP90-PI3K dual inhibitor. Our compound, named DHP1808, was found to suppress A375 cell proliferation through apoptosis induction by activating the Fas/FasL signaling pathway; it also induced cell-cycle arrest and inhibited the cell migration and invasion of A375 cells by interfering with Hsp90-EGFR interactions and downstream signaling pathways. Our results indicate that DHP1808 could be a promising lead compound for the Hsp90/PI3K dual inhibitor.

SUBMITTER: Zhao Q 

PROVIDER: S-EPMC7084941 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5504998 | biostudies-other
| S-EPMC8353760 | biostudies-literature
| S-EPMC3790180 | biostudies-other
| S-EPMC8351599 | biostudies-literature
| S-EPMC5295387 | biostudies-literature
| S-EPMC7476731 | biostudies-literature
| S-EPMC3272303 | biostudies-literature
| S-EPMC7579811 | biostudies-literature
| S-EPMC3435475 | biostudies-literature
| S-EPMC7310254 | biostudies-literature